Skip to main content

Table 5 Multivariate logistic regression analyses of the risk factors for radiation pneumonitis

From: Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients

Factor

P value

OR (95% CI)

Overlap time of TKI and TRT (d)

 < 34

  

 ≥ 34

0.159

3.68 (0.60–22.52)

GTV volume (ml)

 < 21

  

 ≥ 21

0.017

17.53 (1.68–182.92)

Ipsilateral lung V20 (%)

 < 25

  

 ≥ 25

0.030

7.40 (1.21–45.34)

  1. TKI tyrosine kinase inhibitor, TRT thoracic radiotherapy, GTV gross tumor volume, OR odds ratio, CI confidence interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us